172 related articles for article (PubMed ID: 28916995)
1. Effects of environmental enrichment on self-administration of the short-acting opioid remifentanil in male rats.
Hofford RS; Chow JJ; Beckmann JS; Bardo MT
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3499-3506. PubMed ID: 28916995
[TBL] [Abstract][Full Text] [Related]
2. Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.
Maguire DR; Gerak LR; France CP
J Pharmacol Exp Ther; 2013 Dec; 347(3):557-63. PubMed ID: 24042159
[TBL] [Abstract][Full Text] [Related]
3. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat.
Cooper ZD; Truong YN; Shi YG; Woods JH
J Pharmacol Exp Ther; 2008 Sep; 326(3):920-9. PubMed ID: 18515643
[TBL] [Abstract][Full Text] [Related]
4. Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats.
Panlilio LV; Schindler CW
Psychopharmacology (Berl); 2000 May; 150(1):61-6. PubMed ID: 10867977
[TBL] [Abstract][Full Text] [Related]
5. Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.
Maguire DR; France CP
Drug Alcohol Depend; 2020 Jul; 212():108043. PubMed ID: 32497977
[TBL] [Abstract][Full Text] [Related]
6. Effect of environmental enrichment on escalation of cocaine self-administration in rats.
Gipson CD; Beckmann JS; El-Maraghi S; Marusich JA; Bardo MT
Psychopharmacology (Berl); 2011 Mar; 214(2):557-66. PubMed ID: 21057774
[TBL] [Abstract][Full Text] [Related]
7. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats.
Cooper ZD; Shi YG; Woods JH
Psychopharmacology (Berl); 2010 Oct; 212(3):369-78. PubMed ID: 20686752
[TBL] [Abstract][Full Text] [Related]
8. Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys.
Weed PF; France CP; Gerak LR
J Pharmacol Exp Ther; 2017 Jul; 362(1):59-66. PubMed ID: 28438777
[TBL] [Abstract][Full Text] [Related]
9. Delay discounting of food and remifentanil in rhesus monkeys.
Maguire DR; Gerak LR; France CP
Psychopharmacology (Berl); 2013 Sep; 229(2):323-30. PubMed ID: 23636304
[TBL] [Abstract][Full Text] [Related]
10. Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.
Sukhtankar DD; Lagorio CH; Ko MC
Eur J Pharmacol; 2014 Dec; 745():182-9. PubMed ID: 25446568
[TBL] [Abstract][Full Text] [Related]
11. Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer.
Bertz JW; Jackson EL; Barron DR; Woods JH
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):137-47. PubMed ID: 26580131
[TBL] [Abstract][Full Text] [Related]
12. Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.
Swain Y; Muelken P; Skansberg A; Lanzdorf D; Haave Z; LeSage MG; Gewirtz JC; Harris AC
Psychopharmacology (Berl); 2020 Aug; 237(8):2279-2291. PubMed ID: 32388620
[TBL] [Abstract][Full Text] [Related]
13. Differential behavioral functioning in the offspring of rats with high vs. low self-administration of the opioid agonist remifentanil.
Rezvani AH; Wells C; Hawkey A; Blair G; Koburov R; Ko A; Schwartz A; Kim VJ; Levin ED
Eur J Pharmacol; 2021 Oct; 909():174407. PubMed ID: 34363830
[TBL] [Abstract][Full Text] [Related]
14. Self-administration of cocaine and remifentanil by monkeys under concurrent-access conditions.
Huskinson SL; Freeman KB; Woolverton WL
Psychopharmacology (Berl); 2015 Jan; 232(2):321-30. PubMed ID: 24961564
[TBL] [Abstract][Full Text] [Related]
15. Self-administration of cocaine-remifentanil mixtures by monkeys: an isobolographic analysis.
Woolverton WL; Wang Z; Vasterling T; Tallarida R
Psychopharmacology (Berl); 2008 Jun; 198(3):387-94. PubMed ID: 18461311
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging study of the physiological and self-reported effects of repeated, rapid infusion of remifentanil in people with opioid use disorder and physical dependence on fentanyl.
Lile JA; Shellenberg TP; Babalonis S; Hatton KW; Hays LR; Rayapati AO; Stoops WW; Wesley MJ
Psychopharmacology (Berl); 2024 Jun; 241(6):1227-1236. PubMed ID: 38383903
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats.
Blair G; Wells C; Ko A; Modarres J; Pace C; Davis JM; Rezvani AH; Rose JE; Levin ED
Pharmacol Biochem Behav; 2020 Jun; 193():172919. PubMed ID: 32246985
[TBL] [Abstract][Full Text] [Related]
18. Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats.
Maguire DR; Minervini V; Dodda V; France CP
Behav Pharmacol; 2020 Apr; 31(2&3):216-220. PubMed ID: 31577559
[TBL] [Abstract][Full Text] [Related]
19. Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil.
Porter-Stransky KA; Bentzley BS; Aston-Jones G
Addict Biol; 2017 Mar; 22(2):303-317. PubMed ID: 26598295
[TBL] [Abstract][Full Text] [Related]
20. Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats.
Ishida R; Nikai T; Hashimoto T; Tsumori T; Saito Y
Anesth Analg; 2012 Jan; 114(1):224-9. PubMed ID: 22025495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
